97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

292 trials found

diseases per page:

Showing 1 to 10 of 292 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05753267 (ClinicalTrials.gov)	February 28, 2023	22/2/2023	Fenofibrate in Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Fenofibrate in Patient With Ulcerative Colitis	Inflammatory Bowel Diseases	Drug: Mesalamine;Drug: Fenofibrate 160mg	Tanta University	Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;Hend El-Said Abo Mansour, Faculty of Pha ...	Recruiting	18 Years	75 Years	All	60	Phase 2/Phase 3	Egypt
2	NCT05567068 (ClinicalTrials.gov)	February 1, 2023	1/10/2022	Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis	Repurposing Atorvastatin in Patients With Ulcerative Colitis Treated With Mesalamineby Modulation of ...	Inflammatory Bowel Diseases	Drug: Atorvastatin 80mg;Drug: Mesalamine	Tanta University	NULL	Not yet recruiting	18 Years	75 Years	All	44	Phase 2	NULL
3	NCT05574387 (ClinicalTrials.gov)	January 20, 2023	6/10/2022	Metformin as Added on Therapy in Patients With Ulcerative Colitis	Metformin, The Biguanide Derivative, as Adjuvant Therapy in Patients With Ulcerative Colitis Treated ...	Inflammatory Bowel Diseases	Drug: Metformin	Tanta University	Principal Investigator Sahar El-Haggar, Prof Clinical pharmacy Department- Tanta University;Principa ...	Recruiting	18 Years	75 Years	All	46	Phase 2	Egypt
4	NCT05316220 (ClinicalTrials.gov)	December 31, 2022	31/3/2022	A Study to Assess Adverse Events and Change in Disease Condition of MesalamineCapsules in Children A ...	A Randomized, Double-blind Study to Assess the Safety and Efficacy of MesalamineDelayed-release Caps ...	Ulcerative Colitis (UC)	Drug: Mesalamine;Drug: Placebo	AbbVie	NULL	Not yet recruiting	5 Years	17 Years	All	80	Phase 3	United States;Puerto Rico
5	NCT05561062 (ClinicalTrials.gov)	December 1, 2022	27/9/2022	Atorvastatin in Patients With Ulcerative Colitis	Combination of Atorvastatin and Mesalazineto Enhance Anti-inflammatory Effects and Attenuates Progre ...	Inflammatory Bowel Diseases	Drug: Atorvastatin 80mg	Tanta University	NULL	Not yet recruiting	18 Years	75 Years	All	50	Phase 2	NULL
6	NCT05553704 (ClinicalTrials.gov)	November 1, 2022	20/9/2022	Metformin in Patients With Ulcerative Colitis Treated With Mesalamine	Clinical Study to Compare the Possible Efficacy of Metformin in Patients With Ulcerative Colitis Tre ...	Inflammatory Bowel Diseases	Drug: Metformin	Tanta University	NULL	Recruiting	18 Years	75 Years	All	52	Phase 2	Egypt
7	NCT05626166 (ClinicalTrials.gov)	November 2022	9/11/2022	the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis	Clinical Study Evaluating the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis Tre ...	Ulcerative Colitis	Drug: Placebo;Drug: Diosmin	Tanta University	NULL	Not yet recruiting	18 Years	N/A	All	60	Phase 3	NULL
8	NCT05558761 (ClinicalTrials.gov)	October 10, 2022	25/9/2022	Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colit ...	Inflammatory Bowel Diseases	Drug: Pentoxifylline 400 MG	Tanta University	NULL	Recruiting	18 Years	75 Years	All	50	Phase 2	Egypt
9	NCT05119140 (ClinicalTrials.gov)	June 10, 2022	20/10/2021	HCQ for Non Europeans With Mild to Severe UC	Administration of Hydroxychloroquine (Plaquenil) to Individuals of Non-European Ancestry for the Tre ...	Ulcerative Colitis (Disorder)	Drug: Hydroxychloroquine;Drug: Mesalamine	Icahn School of Medicine at Mount Sinai	Crohn's and Colitis Foundation	Recruiting	18 Years	N/A	All	20	Phase 1/Phase 2	United States
10	ITMCTR2100005038	2021-07-15	2021-07-09	Modified Shenling Baizhu Powder in the Treatment of Ulcerative Colitis in the Remission Phase: a Ser ...	Modified Shenling Baizhu Powder in the Treatment of Ulcerative Colitis in the Remission Phase: a Ser ...	Ulcerative Colitis	Experimental group:SLBZP Granule and Mesalazine;Control group:Mesalazine;	The First Affiliated Hospital of Guangzhou University of Chinese Medicine	NULL	Pending	18	75	Both	Experimental group:3;Control group:3;	N/A	China

First Previous1 2 3 4 5…30Next Last